» Articles » PMID: 21403864

Hsp70 and Its Molecular Role in Nervous System Diseases

Overview
Journal Biochem Res Int
Publisher Wiley
Specialty Biochemistry
Date 2011 Mar 16
PMID 21403864
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Heat shock proteins (HSPs) are induced in response to many injuries including stroke, neurodegenerative disease, epilepsy, and trauma. The overexpression of one HSP in particular, Hsp70, serves a protective role in several different models of nervous system injury, but has also been linked to a deleterious role in some diseases. Hsp70 functions as a chaperone and protects neurons from protein aggregation and toxicity (Parkinson disease, Alzheimer disease, polyglutamine diseases, and amyotrophic lateral sclerosis), protects cells from apoptosis (Parkinson disease), is a stress marker (temporal lobe epilepsy), protects cells from inflammation (cerebral ischemic injury), has an adjuvant role in antigen presentation and is involved in the immune response in autoimmune disease (multiple sclerosis). The worldwide incidence of neurodegenerative diseases is high. As neurodegenerative diseases disproportionately affect older individuals, disease-related morbidity has increased along with the general increase in longevity. An understanding of the underlying mechanisms that lead to neurodegeneration is key to identifying methods of prevention and treatment. Investigators have observed protective effects of HSPs induced by preconditioning, overexpression, or drugs in a variety of models of brain disease. Experimental data suggest that manipulation of the cellular stress response may offer strategies to protect the brain during progression of neurodegenerative disease.

Citing Articles

Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.

Church T, Margolis S Front Cell Dev Biol. 2025; 12:1531797.

PMID: 39990094 PMC: 11842346. DOI: 10.3389/fcell.2024.1531797.


Lateral hypothalamic area high-frequency deep brain stimulation rescues memory decline in aged rat: behavioral, molecular, and electrophysiological study.

Hussein A, Abouelnaga A, Obydah W, Saad S, Abass M, Yehia A Pflugers Arch. 2025; 477(3):371-391.

PMID: 39836224 PMC: 11825635. DOI: 10.1007/s00424-024-03059-z.


Structural insights into GrpEL1-mediated nucleotide and substrate release of human mitochondrial Hsp70.

Morizono M, McGuire K, Birouty N, Herzik Jr M Nat Commun. 2024; 15(1):10815.

PMID: 39737924 PMC: 11685456. DOI: 10.1038/s41467-024-54499-1.


4-Hydroxynonenal from Mitochondrial and Dietary Sources Causes Lysosomal Cell Death for Lifestyle-Related Diseases.

Yamashima T Nutrients. 2024; 16(23).

PMID: 39683565 PMC: 11644221. DOI: 10.3390/nu16234171.


Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration.

Tenchov R, Sasso J, Zhou Q ACS Chem Neurosci. 2024; 15(15):2665-2694.

PMID: 38996083 PMC: 11311141. DOI: 10.1021/acschemneuro.4c00184.


References
1.
Selmaj K, Brosnan C, Raine C . Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: implications for multiple sclerosis. Neurology. 1992; 42(4):795-800. DOI: 10.1212/wnl.42.4.795. View

2.
Singh-Jasuja H, Hilf N, Schild H . The role of heat shock proteins and their receptors in the activation of the immune system. Biol Chem. 2001; 382(4):629-36. DOI: 10.1515/BC.2001.074. View

3.
Mycko M, Cwiklinska H, Walczak A, Libert C, Raine C, Selmaj K . A heat shock protein gene (Hsp70.1) is critically involved in the generation of the immune response to myelin antigen. Eur J Immunol. 2008; 38(7):1999-2013. DOI: 10.1002/eji.200737661. View

4.
Selmaj K, Brosnan C, Raine C . Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A. 1991; 88(15):6452-6. PMC: 52103. DOI: 10.1073/pnas.88.15.6452. View

5.
Dong Z, Wolfer D, Lipp H, Bueler H . Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. Mol Ther. 2004; 11(1):80-8. DOI: 10.1016/j.ymthe.2004.09.007. View